BETHLEHEM, Pa., Oct. 11, 2017 -- OraSure Technologies, Inc. (NASDAQ:OSUR) has scheduled its regular earnings conference call covering 2017 third quarter financial results, 2017 fourth quarter financial guidance and certain business developments for 5:00 p.m. ET (2:00 p.m. PT) on Wednesday, November 1, 2017.
| November 1, 2017 Schedule | |
| 4:00 p.m. ET | 2017 third quarter financial results press release will be distributed. |
| 4:50 p.m. ET | To participate in the conference call, dial 844-831-3030 (Domestic) or 315-625-6887 (International) and reference Conference ID #90105011. |
| 5:00 p.m. ET | Conference call and simultaneous Webcast begins. |
The conference call will also be webcast live and may be accessed on the Investor Relations page of OraSure’s website, www.orasure.com. Please click on the webcast link and follow the prompts for registration and access 10 minutes prior to the call.
If you are unable to participate, a replay of the call will be archived on OraSure’s website shortly after the call has ended and will be available for seven days. A replay of the call can also be accessed until midnight, November 8, 2017 by dialing 855-859-2056 (Domestic) or 404-537-3406 (International) and entering the Conference ID #90105011.
COMPANY CONTACT: Joni Messenlehner, OraSure Technologies, Inc. 610-882-1820, or [email protected].


Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
Boeing Secures $8.6 Billion Pentagon Contract for F-15 Jets for Israel
Citigroup to Exit Russia With Sale of AO Citibank to Renaissance Capital
Vietnam’s EV Taxi Giant GSM Eyes Hong Kong IPO With $2–3 Billion Valuation
Leapmotor Targets 4 Million Annual EV Sales as Global Expansion Accelerates
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
Boeing Secures Multi-Billion Dollar Defense Contracts for F-15IA Jets and E-4B Aircraft Support
Applied Digital Stock Rises on AI Cloud Spinoff Plan and ChronoScale Launch
Hyundai Faces Deadline on Russia Plant Buyback Amid Ukraine War and Sanctions
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
China’s Iron Ore Buyer Pressures Mining Giants as New Supply Shifts Market Power
SoftBank Completes $41 Billion OpenAI Investment in Historic AI Funding Round
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro
Lloyds Banking Group to Close Invoice Factoring Business by End of 2025
Lockheed Martin Secures $92.8M AEGIS Sustainment Contract from U.S. Navy
China’s LandSpace Takes Aim at SpaceX With Reusable Rocket Ambitions
Australia’s Modern Gold Rush: Hobby Prospectors Flock to Victoria’s Golden Triangle 



